Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q2 2025 · 10-Q
Revenue$283.79M$283.79M−0.9% vs Q2 2024 Net Income$54.38M$54.38M+1.5% vs Q2 2024 EPS Diluted$1.09$1.09+1.9% vs Q2 2024 Gross Profit$157,382,000−1.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$69,800,000+11.8% Free Cash Flowderived$67,773,000+13.9% Margins · derivedGross margin55.5%−0.4 pt vs Q2 2024
Operating margin29.7%−1.1 pt vs Q2 2024
Net margin19.2%+0.5 pt vs Q2 2024
ended Sep 30, 2024 · filed Nov 7, 2024 · 38 d after period end